06-reference/research

mac challenge vs drip completion format

2026-06-16·research-brief·source: deep-research
macinfo-product-strategycourse-completionchallenge-formatcohort-based-course

Drip vs All-at-Once vs Challenge: Which Format Maximizes MAC Completion (and Is the 70-80% Challenge Number Real)?

The question

Drip vs all-at-once vs challenge format for MAC: which maximizes completion given email-native delivery, and should MAC be reframed as a paid challenge (70-80% completion) rather than a self-paced course (3-5%)? Context: derived from the 2026-06-13 failure-mode brief, where catastrophic non-consumption (3-5% completion) was named the silent compounding killer of low-ticket products — completion drives testimonials, referrals, avoided refunds, and backend conversion.

What we already know (from the vault)

What the web says

Convergences and contradictions

Synthesis for RDCO

Recommendation: ship MAC as a drip-paced, time-boxed cohort challenge — but treat it as an A/B-able wrapper around the same executable IP, not a rebuild. The format question is mostly a sequencing-and-deadline decision, and all three options share the identical Layer-1 playbook. The lowest-cost, highest-completion path is: keep MAC's 8 phases, gate them to a fixed N-day calendar (one phase per day or per two days), wrap a start/end date and a "ship your artifact by Friday" deadline around it, and deliver the daily prompt + nudge email-natively (Resend, the channel already specced for the free drip). All-at-once is the format to avoid: it maximizes overwhelm and abandonment with zero offsetting benefit for a product whose whole value is doing the work. Pure evergreen self-paced is the second-worst — it strips out the one cheap lever (deadline urgency) RDCO gets for free.

The mechanism that actually drives the lift is not "cohort" — it's deadline + daily output + low-friction delivery, and MAC already has two of the three. MAC's executable nature supplies "daily output" for free (you produce a real artifact each phase). Email-native delivery supplies low friction (no platform login). The only missing ingredient is the deadline/accountability layer, and that is exactly what a challenge wrapper adds at near-zero marginal cost. RDCO should be skeptical that adding live cohort facilitation (the expensive, non-scaling part of CBCs) is worth it at v1 — the altMBA 96% number bundles live human teaching that RDCO can't staff solo. The cheap 80% of the benefit is the deadline and the daily cadence; capture that first, measure, and only add live/cohort accountability if instrumented completion stalls.

Minimum-viable challenge wrapper (solo-operator, no live facilitation): (1) Fixed enrollment window with a named start date — buyers all begin the same Monday (creates the cohort/visibility effect without a community platform). (2) One email per day for ~5-8 days, each unlocking one MAC phase with a single concrete "ship this artifact today" ask. (3) A public-ish completion artifact (the buyer's own test-coverage report / data model) as the daily output that creates self-accountability. (4) A re-engagement nudge if a phase goes uncompleted by the next day. (5) A completion moment ("you shipped X") that triggers the testimonial ask and the backend upgrade offer. This is the existing free 5-day drip's structure, promoted from lead-magnet to paid-product spine. Instrument per-phase completion from day one — it is the metric, per the 2026-06-13 brief, that the entire literature is silent on measuring honestly.

Be honest about the number with the founder: do not put "70-80% completion" or "83% upgrade" in MAC's own planning math or sales copy as fact — they are vendor folklore. The defensible claims are: (a) self-paced passive completion is genuinely 3-20% (peer-reviewed); (b) scheduling + deadlines produce a real, repeatable completion lift (direction is solid); (c) the magnitude of that lift, measured neutrally, looks more like 1.3-1.5x than 14x. MAC's executable format plausibly does better than a typical course because output is forced — but that is a hypothesis to measure on RDCO's own first cohort, not a number to import.

Open follow-ups

Related

Sources